Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus lidocaine retrobulbar anesthesia in cataract surgery
IRCT20210415050976N7Phase 2Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in cataract comparing Lidocaine 2% retrobulbar with Dexmedetomidine + lidocaine 2% retrobulbar (2 arms). Primary endpoints: Pain and Hemodynamic changes. Started Nov 2021; status: completed.
02
Drugs
dexmedetomidinelidocaine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20210415050976N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210415050976N7.